Search Results - "Capelôa, T"

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort by Apicella, M, Migliore, C, Capelôa, T, Menegon, S, Cargnelutti, M, Degiuli, M, Sapino, A, Sottile, A, Sarotto, I, Casorzo, L, Cassoni, P, De Simone, M, Comoglio, P M, Marsoni, S, Corso, S, Giordano, S

“…Amplification of the MET oncogene occurs in 2–4% of gastroesophageal cancers and defines a small and aggressive subset of tumors. Although in vitro studies…”
Get full text

Combined anti-MET/EGFR treatment results in complete tumor regression and prevents resistance onset in a MET-amplified gastroesophageal xenopatient cohort by Giordano, S, Apicella, M, Migliore, C, Capeloa, T, Menegon, S, Cargnelutti, M, Sapino, A, Cassoni, P, Marsoni, S, Corso, S

Get full text

852 - Combined anti-MET/EGFR treatment results in complete tumor regression and prevents resistance onset in a MET-amplified gastroesophageal xenopatient cohort by Giordano, S., Apicella, M., Migliore, C., Capeloa, T., Menegon, S., Cargnelutti, M., Sapino, A., Cassoni, P., Marsoni, S., Corso, S.

Get full text

Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity by Weber, Daniela D, Aminzadeh-Gohari, Sepideh, Thapa, Maheshwor, Redtenbacher, Anna-Sophia, Catalano, Luca, Capelôa, Tânia, Vazeille, Thibaut, Emberger, Michael, Felder, Thomas K, Feichtinger, René G, Koelblinger, Peter, Dallmann, Guido, Sonveaux, Pierre, Lang, Roland, Kofler, Barbara

“…Abstract Background Growing evidence supports the use of low-carbohydrate/high-fat ketogenic diets as an adjunctive cancer therapy. However, it is unclear…”
Get full text